Groene Hart Ziekenhuis

Enabling Evolutionary Therapy in metastatic cancer lacking serum biomarkers

Evolutionary therapy (ET) aims to anticipate and steer tumor evolution by adjusting treatment timing and dosing, often to control rather than eradicate tumor burden. Clinical use requires reliable monitoring of tumor dynamics to inform mathematical models that guide therapy. In c...